13F filer · CIK 1037792 ↗
Paradigm Capital Management Inc
You are looking at Q2 2025. See the latest, Q2 2026 →
Reported value
$2.05B
+14% on the quarter before
Positions
122
4 new · 9 sold out
Top 10
55.4%
of the value
Est. gain
+$252.9M
on stocks held all quarter
Est. return
+14.7%
on those stocks since Q1 2025
Positions as of Jun 30, 2025, from Paradigm Capital Management Inc's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2025. Striped tiles are options.
Largest buys
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Owens And Minor, Inc.~$17.5MAdded · 0.0% → 0.9%+1,918,700 shares
- Enovis Corporation~$10.3MAdded · 1.7% → 1.7%+326,900 shares
- Integra Lifesciences Holdings Corp~$9.8MAdded · 1.7% → 1.3%+796,300 shares
- Orthofix Medical Inc.~$9.6MAdded · 2.2% → 1.8%+858,900 shares
- Zumiez, Inc.~$8.4MAdded · 0.1% → 0.5%+635,691 shares
- Quidel Corp~$8.0MAdded · 0.9% → 1.0%+276,790 shares
- Xerox Corp~$3.0MAdded · 0.3% → 0.5%+564,048 shares
- J Jill Group~$1.8MAdded · 1.0% → 0.8%+125,838 shares
- MaxLinear~$1.7MAdded · 0.1% → 0.2%+122,325 shares
- Caleres Inc~$1.7MAdded · 0.7% → 0.5%+138,500 shares
Largest sells
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- American Woodmark Corporation~$18.0MCut · 1.2% → 0.1%−336,900 shares
- Si-Bone, Inc.~$11.4MCut · 1.0% → 0.6%−604,924 shares
- Semtech~$6.6MSold out · 0.4% → 0.0%−191,600 shares
- Axcelis Technologies~$6.6MCut · 0.5% → 0.3%−94,000 shares
- Nature`S Sunshine Products, Inc.~$5.7MCut · 0.5% → 0.3%−384,038 shares
- Extreme Networks~$4.4MCut · 3.8% → 4.4%−242,700 shares
- Cohu Inc.~$3.7MCut · 0.8% → 0.7%−192,650 shares
- Calix Inc~$3.4MCut · 2.0% → 2.5%−63,100 shares
- Ribbon Communications Inc~$3.1MCut · 2.1% → 1.7%−763,000 shares
- Jabil~$2.8MCut · 4.3% → 5.9%−13,000 shares
Holdings
As of Jun 30, 2025. Changes are in shares against Mar 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BroadcomCOM · shares 0% · price +64.6% | 10.9% | $223.0M | +$87.5M | ||||||||
| ModineCOM · shares −0.8% · price +28.3% | 7.8% | $160.9M | +$35.5M | ||||||||
| FabrinetCOM · shares 0% · price +49.2% | 7.6% | $156.6M | +$51.6M | ||||||||
| JabilCOM · shares −2.3% · price +60.3% | 5.9% | $121.7M | +$45.8M | ||||||||
| Onto InnovationCOM · shares +0.7% · price −16.8% | 5.5% | $112.3M | −$22.6M | ||||||||
| Extreme NetworksCOM · shares −4.6% · price +35.7% | 4.4% | $89.4M | +$23.5M | ||||||||
| Ducommun IncCOM · shares −1.9% · price +42.4% | 4.0% | $82.4M | +$24.5M | ||||||||
| Insight EnterprisesCOM · shares −0.5% · price −7.9% | 4.0% | $81.9M | −$7.1M | ||||||||
| Globus MedicalCOM · shares −0.7% · price −19.4% | 2.7% | $55.6M | −$13.4M | ||||||||
| Ensign Group, Inc.COM · shares −0.7% · price +19.2% | 2.6% | $53.1M | +$8.6M | ||||||||
| Calix IncCOM · shares −6.1% · price +50.1% | 2.5% | $51.3M | +$17.1M | ||||||||
| Veeco InstrumentsCOM · shares +1.3% · price +1.2% | 2.4% | $49.0M | +$571,200 | ||||||||
| EntegrisCOM · shares +1.3% · price −7.8% | 2.1% | $43.8M | −$3.7M | ||||||||
| EnersysCOM · shares −1.6% · price −6.3% | 2.0% | $40.8M | −$2.8M | ||||||||
| Enviri CorpCOM · shares −1.0% · price +30.5% | 1.9% | $38.4M | +$9.0M | ||||||||
| Concentrix CorpCOM · shares −5.7% · price −5.0% | 1.8% | $37.3M | −$2.0M | ||||||||
| Orthofix Medical Inc.COM · shares +35% · price −31.6% | 1.8% | $37.2M | −$12.8M | ||||||||
| Ribbon Communications IncCOM · shares −8.0% · price +2.3% | 1.7% | $35.1M | +$787,338 | ||||||||
| Enovis CorporationCOM · shares +42% · price −17.9% | 1.7% | $34.9M | −$5.4M | ||||||||
| Pennant Group Inc.COM · shares −0.4% · price +18.7% | 1.4% | $28.4M | +$4.5M | ||||||||
| MimedxCOM · shares −4.9% · price −19.6% | 1.3% | $27.2M | −$6.6M | ||||||||
| Integra Lifesciences Holdings CorpCOM · shares +57% · price −44.2% | 1.3% | $26.8M | −$13.5M | ||||||||
| CerenceCOM · shares +0.7% · price +29.2% | 1.3% | $26.1M | +$5.9M | ||||||||
| Penguin Solutions IncCOM · shares +2.5% · price +14.0% | 1.1% | $22.8M | +$2.7M | ||||||||
| Quidel CorpCOM · shares +59% · price −17.6% | 1.0% | $21.5M | −$2.9M | ||||||||
| Total · 122 positions | 100% | $2.05B | +$252.9M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2025 to Q2 2025: 118 stocks held throughout, up $252.9M (+14.7%).
- Broadcom+$87.5M+65%
- Fabrinet+$51.6M+49%
- Jabil+$45.8M+60%
- Modine+$35.5M+28%
- Ducommun Inc+$24.5M+42%
- Insight Enterprises−$7.1M−8%
- Orthofix Medical Inc.−$12.8M−32%
- Globus Medical−$13.4M−19%
- Integra Lifesciences Holdings Corp−$13.5M−44%
- Onto Innovation−$22.6M−17%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $3.67B+41% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $2.61B+10% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $2.38B+3% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $2.31B+12% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $2.05B+14% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.80B−17% | SEC ↗ |
| Q4 2024 | Feb 18, 2025 | $2.16B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $2.25B+3% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $2.19B+5% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $2.09B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.92B+10% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.74B−0% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.75B+16% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $1.51B−0% | SEC ↗ |
| Q4 2022 | Feb 3, 2023 | $1.51B+9% | SEC ↗ |
| Q3 2022 | Oct 26, 2022 | $1.39B−6% | SEC ↗ |
| Q2 2022 | Aug 2, 2022 | $1.47B−20% | SEC ↗ |
| Q1 2022 | May 25, 2022 | $1.85B−17% | SEC ↗ |
| Q4 2021 | Feb 9, 2022 | $2.24B+15% | SEC ↗ |
| Q3 2021 | Nov 8, 2021 | $1.94B−7% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $2.08B+8% | SEC ↗ |
| Q1 2021 | May 5, 2021 | $1.93B+15% | SEC ↗ |
| Q4 2020 | Jan 20, 2021 | $1.67B+41% | SEC ↗ |
| Q3 2020 | Oct 20, 2020 | $1.19B+9% | SEC ↗ |
| Q2 2020 | Aug 3, 2020 | $1.09B+32% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $827.9M−36% | SEC ↗ |
| Q4 2019 | Feb 5, 2020 | $1.30B+16% | SEC ↗ |
| Q3 2019 | Nov 7, 2019 | $1.12B+2% | SEC ↗ |
| Q2 2019 | Aug 8, 2019 | $1.10B−4% | SEC ↗ |
| Q1 2019 | May 10, 2019 | $1.14B+12% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $1.02B−20% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $1.27B+3% | SEC ↗ |
| Q2 2018 | Aug 8, 2018 | $1.24B+5% | SEC ↗ |
| Q1 2018 | Apr 9, 2018 | $1.18B+1% | SEC ↗ |
| Q4 2017 | Feb 7, 2018 | $1.17B+2% | SEC ↗ |
| Q3 2017 | Nov 6, 2017 | $1.15B+4% | SEC ↗ |
| Q2 2017 | Aug 10, 2017 | $1.11B+5% | SEC ↗ |
| Q1 2017 | May 9, 2017 | $1.06B+3% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $1.03B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $953.0M+16% | SEC ↗ |
| Q2 2016 | Aug 9, 2016 | $820.6M−4% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $858.8M | SEC ↗ |